Disc Medicine (IRON) Shares Issued (2020 - 2025)
Disc Medicine (IRON) posted quarterly Shares Issued of $3.3 million for Q4 2025, up 13.9% year-over-year from $2.9 million in Q4 2024, and up 13.9% quarter-over-quarter from $2.9 million in Q4 2024.
Disc Medicine (IRON) Shares Issued (2020 - 2025) Analysis & Trends
Disc Medicine (IRON) has reported Shares Issued for 6 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Issued rose 13.9% year-over-year to $3.3 million; the TTM figure through Dec 2025 stood at $3.3 million (up 13.9% YoY), while the FY2025 annual figure was $3.3 million, up 13.9% from the prior year.
- Shares Issued improved to $3.3 million in Q4 2025 per IRON's latest filing, from $2.9 million in the prior quarter.
- Across five years, Shares Issued topped out at $10.6 million in Q1 2021 and bottomed at $1.3 million in Q1 2022.
- Historically, Shares Issued has averaged $4.0 million across 5 years, with a median of $2.9 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Issued tumbled 87.24% — and 2023, when it surged 87.51%.
- Disc Medicine's Shares Issued stood at $1.5 million in 2021, then surged by 81.29% to $2.6 million in 2022, then declined by 6.88% to $2.5 million in 2023, then advanced by 16.73% to $2.9 million in 2024, then grew by 13.9% to $3.3 million in 2025.
- Business Quant data shows IRON's Shares Issued at $3.3 million in Q4 2025, $2.9 million in Q4 2024, and $3.0 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Disc Medicine | 3.02 Bn | 3.02 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Dec 31, 2023 | 2.46 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.56 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.19 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Dec 31, 2022 | 2.64 Mn |